XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Employee Benefits (Tables)
 3 Months Ended
Oct. 31, 2024
Disclosure Text Block Supplement [Abstract]  
Nonvested Restricted Stock Shares Activity [Table Text Block] The following tables summarize legally non-vested restricted stock award activity for the periods presented:
   Nine Months Ended October 31, 2024 
             
   Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
Vesting Term
(in years)		 
                
Non-Vested at January 31, 2024  162,855   $5,369    2 
Granted   63,407    2,894      
Forfeited   -    -      
Vested   63,870    2,073      
                
Non-Vested at October 31, 2024  162,392   $6,190    2 
   Nine Months Ended October 31, 2023 
             
   Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
Vesting Term
(in years)		 
                
Non-Vested at January 31, 2023  81,264   $2,320    2 
Granted   113,726    3,945      
Forfeited   -    -      
Vested   32,135    896      
                
Non-Vested at October 31, 2023  162,855   $5,369    2 
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] The Company determined there to be no dilutive impact on earnings per share for the first three quarters of fiscal year 2023. For the three- and nine-months periods ended October 31, 2024, we calculated the diluted weighted average shares as follows (amounts in thousands):
   Three Months Ended
October 31, 2024		  Nine Months Ended
October 31, 2024
Weighted average shares – basic   17,595    17,550 
Dilutive effect of RSUs   128    123 
Weighted average shares – diluted   17,723    17,673